gallium citrate has been researched along with Hepatocellular Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beheshti, M; Dudczak, R; Grumbeck, E; Hamilton, G; Kapiotis, S; Kletter, K; Li, S; Oezer, S; Peck-Radosavljevic, M; Schmid, M | 1 |
| Kume, N; Matsunaga, N; Nishigauchi, K; Shimizu, K; Suga, K | 1 |
2 other study(ies) available for gallium citrate and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Comparison of (11)C-acetate positron emission tomography and (67)Gallium citrate scintigraphy in patients with hepatocellular carcinoma.
Topics: Aged; Aged, 80 and over; Carbon Radioisotopes; Carcinoma, Hepatocellular; Citrates; Female; Gallium; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals | 2006 |
Characterization of hepatic adenoma with atypical appearance on CT and MRI by radionuclide imaging.
Topics: Adenoma, Liver Cell; Adolescent; Adult; Carcinoma, Hepatocellular; Citrates; Diagnosis, Differential; Female; Gallium; Gallium Radioisotopes; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Organotechnetium Compounds; Phytic Acid; Pyridoxal; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Tryptophan | 1997 |